| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |